Search

everythinglearnresearchcommunity

for

Search:↓

AGA might indicate higher risk for severe COVID-19.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Possible link between androgens and COVID-19 severity; more research needed.

Men had worse COVID-19 outcomes than women in New York City.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Finasteride reduces prostate size and PSA levels in young patients.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

New compounds may help treat prostate issues without affecting androgen receptors.